These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12899995)

  • 1. Degradation of components in drug formulations: a comparison between HPLC and DSC methods.
    Ceschel GC; Badiello R; Ronchi C; Maffei P
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1067-72. PubMed ID: 12899995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions.
    McDaid FM; Barker SA; Fitzpatrick S; Petts CR; Craig DQ
    Int J Pharm; 2003 Feb; 252(1-2):235-40. PubMed ID: 12550799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of differential scanning calorimetry for the purity verification of pharmaceutical reference standards.
    Mathkar S; Kumar S; Bystol A; Olawoore K; Min D; Markovich R; Rustum A
    J Pharm Biomed Anal; 2009 Apr; 49(3):627-31. PubMed ID: 19186017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations.
    Mora PC; Cirri M; Mura P
    J Pharm Biomed Anal; 2006 Sep; 42(1):3-10. PubMed ID: 16574368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2004 May; 35(3):449-58. PubMed ID: 15137971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
    Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
    J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast-Scan DSC and its role in pharmaceutical physical form characterisation and selection.
    Ford JL; Mann TE
    Adv Drug Deliv Rev; 2012 Apr; 64(5):422-30. PubMed ID: 22178405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of sennoside A and B with pharmaceutical excipients.
    Verloop Q; Marais AF; de Villiers MM; Liebenberg W
    Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of acetaminophen in pharmaceutical formulations using differential scanning calorimetry. Comparison with spectrophotometric method.
    Campanella L; Magrì AL; Tomassetti M; Rossi V; Vecchio S
    Drug Dev Ind Pharm; 2007 Aug; 33(8):830-40. PubMed ID: 17729100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances and potential applications of modulated differential scanning calorimetry (mDSC) in drug development.
    Knopp MM; Löbmann K; Elder DP; Rades T; Holm R
    Eur J Pharm Sci; 2016 May; 87():164-73. PubMed ID: 26721421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of thioctic acid, magnesium stearate and pyridoxine hydrochloride compatibility.
    Almakaiev M; Vashchenko O; Sofronov D; Budianska L; Lisetski L
    Ceska Slov Farm; 2020; 69(1):43-47. PubMed ID: 32460509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs.
    Nageswara Rao R; Nagaraju V
    J Pharm Biomed Anal; 2003 Oct; 33(3):335-77. PubMed ID: 14550856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of vitamin B6 by means of differential spectrophotometry in pharmaceutical preparations in the presence of magnesium compounds.
    Muszalska I; Puchalska M; Sobczak A
    Acta Pol Pharm; 2011; 68(6):845-51. PubMed ID: 22125948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
    Yoshida MI; Gomes EC; Soares CD; Oliveira MA
    Drug Dev Ind Pharm; 2011 Jun; 37(6):638-47. PubMed ID: 21449701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.